{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:46:55Z","timestamp":1782359215108,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Anusandhan National Research Foundation","doi-asserted-by":"crossref","award":["CRG\/2022\/003194"],"award-info":[{"award-number":["CRG\/2022\/003194"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01944-7","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:02:59Z","timestamp":1782356579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptome profiling reveals the role of XIST\/miR-335-5p regulatory axis as a crucial mediator of chemoresistance in esophageal cancer by influencing EMT and Ferroptosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Kiran","family":"Pasbola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. R.","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Gunjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Kurdia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetika","family":"Suyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"7","key":"1944_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","volume":"17","author":"JA Ajani","year":"2019","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Corvera C, Das P et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17(7):855\u201383. https:\/\/doi.org\/10.6004\/jnccn.2019.0033","journal-title":"J Natl Compr Canc Netw"},{"key":"1944_CR3","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.biopha.2018.11.049","volume":"109","author":"Z Chen","year":"2019","unstructured":"Chen Z, Hu X, Wu Y, Cong L, He X, Lu J, Feng J, Liu D (2019) Long non-coding RNA XIST promotes the development of esophageal cancer by sponging miR-494 to regulate CDK6 expression. Biomed Pharmacother 109:2228\u20132236. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.049","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1944_CR4","doi-asserted-by":"publisher","first-page":"112281","DOI":"10.1016\/j.yexcr.2020.112281","volume":"396","author":"D Chen","year":"2020","unstructured":"Chen D, Chen T, Guo Y, Wang C, Dong L, Lu C (2020) Platycodin D (PD) regulates LncRNA-XIST\/miR-335 axis to slow down bladder cancer progression in vitro and in vivo. Exp Cell Res 396(1):112281. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112281","journal-title":"Exp Cell Res"},{"issue":"6","key":"1944_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s10528-021-10069-4","volume":"59","author":"S Cui","year":"2021","unstructured":"Cui S, Yang CL, Chen DY (2021) LncRNA EWSAT1 regulates the tumorigenesis of NSCLC as a ceRNA by modulating miR-330-5p\/ITGA5 axis. Biochem Genet 59(6):1441\u20131456. https:\/\/doi.org\/10.1007\/s10528-021-10069-4","journal-title":"Biochem Genet"},{"issue":"4","key":"1944_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10616-021-00478-z","volume":"73","author":"D Du","year":"2021","unstructured":"Du D, Cao X, Duan X, Zhang X (2021) Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis. Cytotechnology 73(4):571\u2013584. https:\/\/doi.org\/10.1007\/s10616-021-00478-z","journal-title":"Cytotechnology"},{"issue":"5","key":"1944_CR7","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170696","volume":"37","author":"P Du","year":"2017","unstructured":"Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng G, Liao Y (2017) LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. Biosci Rep 37(5):BSR20170696. https:\/\/doi.org\/10.1042\/BSR20170696","journal-title":"Biosci Rep"},{"key":"1944_CR8","volume-title":"Ferri\u2019s Clinical Advisor 2013: 5 Books in 1","author":"F Ferri","year":"2013","unstructured":"Ferri F (2013) Ferri\u2019s Clinical Advisor 2013: 5 Books in 1, 1st edn. Elsevier, St. Louis (MO)","edition":"1st edn"},{"issue":"1","key":"1944_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12935-020-01684-z","volume":"21","author":"Y Gao","year":"2021","unstructured":"Gao Y, Wang Y, Wang X, Zhao C, Wang F, Du J, Zhang H, Shi H, Feng Y, Li D, Yan J, Yao Y, Hu W, Ding R, Zhang M, Wang L, Huang C, Zhang J (2021) miR-335-5p suppresses gastric cancer progression by targeting MAPK10. Cancer Cell Int 21(1):71. https:\/\/doi.org\/10.1186\/s12935-020-01684-z","journal-title":"Cancer Cell Int"},{"issue":"11","key":"1944_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.39778","volume":"5","author":"F Ge","year":"2022","unstructured":"Ge F, Huo Z, Cai X, Hu Q, Chen W, Lin G, Zhong R, You Z, Wang R, Lu Y, Wang R, Huang Q, Zhang H, Song A, Li C, Wen Y, Jiang Y, Liang H, He J, Liang W, Liu J (2022) Evaluation of clinical and safety outcomes of neoadjuvant immunotherapy combined with chemotherapy for patients with resectable esophageal cancer: a systematic review and meta-analysis. JAMA Netw Open 5(11):e2239778. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.39778","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1944_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10620-024-08269-0","volume":"69","author":"B Guo","year":"2024","unstructured":"Guo B, He M, Ma M, Tian Z, Jin J, Tian G (2024) Long non-coding RNA X-inactive specific transcript promotes esophageal squamous cell carcinoma progression via the MicroRNA 34a\/Zinc finger E-box-binding homeobox 1 pathway. Dig Dis Sci 69(4):1169\u20131181. https:\/\/doi.org\/10.1007\/s10620-024-08269-0","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1944_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/proteomes13010006","volume":"13","author":"S Gupta","year":"2025","unstructured":"Gupta S, Silveira DA, Mombach JCM, Hashimoto RF (2025) DNA damage-induced ferroptosis: a boolean model regulating p53 and non-coding RNAs in drug resistance. Proteomes 13(1):6. https:\/\/doi.org\/10.3390\/proteomes13010006","journal-title":"Proteomes"},{"issue":"22","key":"1944_CR13","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BPL et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074\u20132084. https:\/\/doi.org\/10.1056\/NEJMoa1112088","journal-title":"N Engl J Med"},{"issue":"2","key":"1944_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/mmr.2020.11778","volume":"23","author":"Y Han","year":"2021","unstructured":"Han Y, Wang X, Mao E, Shen B, Huang L (2021) LncRNA FLVCR1-AS1 drives colorectal cancer progression via modulation of the miR-381\/RAP2A axis. Mol Med Rep 23(2):139. https:\/\/doi.org\/10.3892\/mmr.2020.11778","journal-title":"Mol Med Rep"},{"issue":"146","key":"1944_CR15","doi-asserted-by":"publisher","first-page":"113804","DOI":"10.1016\/j.intimp.2024.113804","volume":"27","author":"H Han","year":"2025","unstructured":"Han H, Li Y, Lin Z, Ma X, Huang W, Lu C, Ma R, Han R (2025) Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1. Int Immunopharmacol 27(146):113804. https:\/\/doi.org\/10.1016\/j.intimp.2024.113804","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"1944_CR16","first-page":"1526","volume":"24","author":"J Hao","year":"2019","unstructured":"Hao J, Lai M, Liu C (2019) Expression of miR-335 in triple-negative breast cancer and its effect on chemosensitivity. J BUON 24(4):1526\u20131531","journal-title":"J BUON"},{"issue":"2","key":"1944_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3892\/or.2013.2876","volume":"31","author":"J Hara","year":"2014","unstructured":"Hara J, Miyata H, Yamasaki M, Sugimura K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y (2014) Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer. Oncol Rep 31(2):589\u2013596. https:\/\/doi.org\/10.3892\/or.2013.2876","journal-title":"Oncol Rep"},{"issue":"9\u201310","key":"1944_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1159\/000512621","volume":"106","author":"G Hua","year":"2021","unstructured":"Hua G, Zeng ZL, Shi YT, Chen W, He LF, Zhao GF (2021) LncRNA XIST contributes to cisplatin resistance of lung cancer cells by promoting cellular glycolysis through sponging miR-101-3p. Pharmacology (Basel) 106(9\u201310):498\u2013508. https:\/\/doi.org\/10.1159\/000512621","journal-title":"Pharmacology (Basel)"},{"issue":"6","key":"1944_CR19","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.3892\/ol.2017.7126","volume":"14","author":"Q Kan","year":"2017","unstructured":"Kan Q, Su Y, Yang H (2017) MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2. Oncol Lett 14(6):7622\u20137628. https:\/\/doi.org\/10.3892\/ol.2017.7126","journal-title":"Oncol Lett"},{"key":"1944_CR20","doi-asserted-by":"publisher","unstructured":"Karreth FA, Pandolfi PP (2013) CeRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0202","DOI":"10.1158\/2159-8290.CD-13-0202"},{"issue":"5","key":"1944_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/10799893.2021.2019274","volume":"42","author":"J Li","year":"2022","unstructured":"Li J, Che L, Xu C, Lu D, Xu Y, Liu M, Chai W (2022) XIST\/miR-34a-5p\/PDL1 axis regulated the development of lung cancer cells and the immune function of CD8+ T cells. J Recept Signal Transduct Res 42(5):469\u2013478. https:\/\/doi.org\/10.1080\/10799893.2021.2019274","journal-title":"J Recept Signal Transduct Res"},{"key":"1944_CR22","doi-asserted-by":"publisher","first-page":"110064","DOI":"10.1016\/j.abb.2024.110064","volume":"758","author":"X Li","year":"2024","unstructured":"Li X, Zhao X, Su X, Wen J, Yang S, Qin Y, Yan S, Yao Y, Li X, Wang X (2024) IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells. Arch Biochem Biophys 758:110064. https:\/\/doi.org\/10.1016\/j.abb.2024.110064","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"1944_CR23","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1002\/cam4.1682","volume":"7","author":"R Liu","year":"2018","unstructured":"Liu R, Guo H, Lu S (2018) MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2. Cancer Med 7(9):4598\u20134609. https:\/\/doi.org\/10.1002\/cam4.1682","journal-title":"Cancer Med"},{"issue":"18","key":"1944_CR24","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.18632\/aging.102291","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y (2019) Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335\/SOD2\/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY) 11(18):7830\u20137846. https:\/\/doi.org\/10.18632\/aging.102291","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"1944_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12935-025-03812-z","volume":"25","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zeng Y, Wang S, Chen J, Wang Z, Zhao Y, Gong K, Wang G (2025) LncRNA16 inhibits pyroptosis and promotes platinum resistance in non-small cell lung cancer by sponging miRNA1827 to regulate MBD3\/GSDME expression. Cancer Cell Int 25(1):192. https:\/\/doi.org\/10.1186\/s12935-025-03812-z","journal-title":"Cancer Cell Int"},{"key":"1944_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.biopha.2018.07.046","volume":"106","author":"L Luo","year":"2018","unstructured":"Luo L, Xia L, Zha B, Zuo C, Deng D, Chen M, Hu L, He Y, Dai F, Wu J, Wang C, Wang Y, Zhang Q (2018) MiR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells. Biomed Pharmacother 106:983\u2013990. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.046","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1944_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/jso.24592","volume":"115","author":"GK Malhotra","year":"2017","unstructured":"Malhotra GK, Yanala U, Ravipati A, Follet M, Vijayakumar M, Are C (2017) Global trends in esophageal cancer. J Surg Oncol 115(5):564\u2013579. https:\/\/doi.org\/10.1002\/jso.24592","journal-title":"J Surg Oncol"},{"issue":"1","key":"1944_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12957-021-02274-7","volume":"19","author":"Q Meng","year":"2021","unstructured":"Meng Q, Wang N, Duan G (2021) Long non-coding RNA XIST regulates ovarian cancer progression via modulating miR-335\/BCL2L2 axis. World J Surg Oncol 19(1):165. https:\/\/doi.org\/10.1186\/s12957-021-02274-7","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1944_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/curroncol33010037","volume":"33","author":"H Murakami","year":"2026","unstructured":"Murakami H, Wang J, Yu H (2026) Discovery of a ferroptosis-related lncRNA-miRNA-mRNA gene signature in endometrial cancer through a comprehensive co-expression network analysis. Curr Oncol 33(1):37. https:\/\/doi.org\/10.3390\/curroncol33010037","journal-title":"Curr Oncol"},{"key":"1944_CR30","doi-asserted-by":"publisher","unstructured":"Pandey P, Suyal G, Aprajita, Pasbola K, Sharma R (2023) NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells. Funct Integr Genomics 23(2):111. https:\/\/doi.org\/10.1007\/s10142-023-01041-z.","DOI":"10.1007\/s10142-023-01041-z"},{"issue":"19","key":"1944_CR31","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.26355\/eurrev_201910_19150","volume":"23","author":"HB Qiu","year":"2019","unstructured":"Qiu HB, Yang K, Yu HY, Liu M (2019) Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p\/CBLL1 axis in non-small cell lung cancer cells. Eur Rev Med Pharmacol Sci 23(19):8391\u20138402. https:\/\/doi.org\/10.26355\/eurrev_201910_19150","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1944_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biocel.2019.05.021","volume":"113","author":"J Shen","year":"2019","unstructured":"Shen J, Hong L, Yu D, Cao T, Zhou Z, He S (2019) LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression. Int J Biochem Cell Biol 113:17\u201326. https:\/\/doi.org\/10.1016\/j.biocel.2019.05.021","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"1944_CR33","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","volume":"27","author":"EC Smyth","year":"2017","unstructured":"Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P et al (2017) Oesophageal Cancer Nat Rev Dis Primers 27(3):17048. https:\/\/doi.org\/10.1038\/nrdp.2017.48","journal-title":"Oesophageal Cancer Nat Rev Dis Primers"},{"issue":"6","key":"1944_CR34","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s12032-014-0982-8","volume":"31","author":"Z Sun","year":"2014","unstructured":"Sun Z, Zhang Z, Liu Z, Qiu B, Liu K, Dong G (2014) MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2. Med Oncol 31(6):982. https:\/\/doi.org\/10.1007\/s12032-014-0982-8","journal-title":"Med Oncol"},{"issue":"6","key":"1944_CR35","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3892\/or.2017.6056","volume":"38","author":"W Sun","year":"2017","unstructured":"Sun W, Zu Y, Fu X, Deng Y (2017) Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy. Oncol Rep 38(6):3347\u20133354. https:\/\/doi.org\/10.3892\/or.2017.6056","journal-title":"Oncol Rep"},{"issue":"9","key":"1944_CR36","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.7150\/jca.55626","volume":"12","author":"Z Sun","year":"2021","unstructured":"Sun Z, Shao B, Liu Z, Dang Q, Guo Y, Chen C, Guo Y, Chen Z, Liu J, Hu S, Yuan W, Zhou Q (2021) LINC01296\/miR-141-3p\/ZEB1-ZEB2 axis promotes tumor metastasis via enhancing epithelial-mesenchymal transition process. J Cancer 12(9):2723\u20132734. https:\/\/doi.org\/10.7150\/jca.55626","journal-title":"J Cancer"},{"issue":"3","key":"1944_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"1944_CR38","doi-asserted-by":"publisher","first-page":"104738","DOI":"10.1016\/j.yexmp.2021.104738","volume":"124","author":"G Suyal","year":"2022","unstructured":"Suyal G, Pandey P, Saraya A, Sharma R (2022) Tumour suppressor role of microRNA-335-5p in esophageal squamous cell carcinoma by targeting TTK (Mps1). Exp Mol Pathol 124:104738. https:\/\/doi.org\/10.1016\/j.yexmp.2021.104738","journal-title":"Exp Mol Pathol"},{"issue":"25","key":"1944_CR39","doi-asserted-by":"publisher","first-page":"8095","DOI":"10.12659\/MSM.916075","volume":"29","author":"LJ Tian","year":"2019","unstructured":"Tian LJ, Wu YP, Wang D, Zhou ZH, Xue SB, Zhang DY, Wei YG, Liu W (2019) Upregulation of long noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is associated with cisplatin resistance in Non-Small Cell Lung Cancer (NSCLC) by downregulating MicroRNA-144-3p. Med Sci Monit 29(25):8095\u20138104. https:\/\/doi.org\/10.12659\/MSM.916075","journal-title":"Med Sci Monit"},{"issue":"6","key":"1944_CR40","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","volume":"13","author":"DJ Uhlenhopp","year":"2020","unstructured":"Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V (2020) Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 13(6):1010\u20131021. https:\/\/doi.org\/10.1007\/s12328-020-01237-x","journal-title":"Clin J Gastroenterol"},{"issue":"19","key":"1944_CR41","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.7150\/jca.32065","volume":"10","author":"M Wang","year":"2019","unstructured":"Wang M, Hu H, Wang Y, Huang Q, Huang R, Chen Y, Ma T, Qiao T, Zhang Q, Wu H, Chen Q, Han D, Wang G, Wang X (2019) Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer. J Cancer 10(19):4603\u20134613. https:\/\/doi.org\/10.7150\/jca.32065","journal-title":"J Cancer"},{"issue":"1","key":"1944_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/15384101.2020.1856497","volume":"20","author":"H Wang","year":"2021","unstructured":"Wang H, Li H, Yu Y, Jiang Q, Zhang R, Sun H, Xing W, Li Y (2021) Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression. Cell Cycle 20(1):39\u201353. https:\/\/doi.org\/10.1080\/15384101.2020.1856497","journal-title":"Cell Cycle"},{"issue":"9","key":"1944_CR43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/1759-7714.14381","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Yao W, Li J, Zhang Q, Wei L (2022) Identification of a novel circ_0001946\/miR-1290\/SOX6 ceRNA network in esophageal squamous cell cancer. Thorac Cancer 13(9):1299\u20131310. https:\/\/doi.org\/10.1111\/1759-7714.14381","journal-title":"Thorac Cancer"},{"key":"1944_CR44","doi-asserted-by":"publisher","first-page":"111534","DOI":"10.1016\/j.cellsig.2024.111534","volume":"127","author":"Y Wang","year":"2025","unstructured":"Wang Y, Pei W, Yang Y, Xia C, Zhang Q, Geng Z, Shi X, Wang F (2025) Inhibition of XIST restrains paclitaxel resistance in breast cancer cells by targeting hsa-let-7d-5p\/ATG16L1 through regulation of autophagy. Cell Signal 127:111534. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111534","journal-title":"Cell Signal"},{"issue":"10","key":"1944_CR45","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.2174\/1386207325666220624093957","volume":"26","author":"W Wei","year":"2023","unstructured":"Wei W, Wang C, Zhang J, Wang L, Wei L, Huang H (2023) The role of the LINC01234\/miR-433-3p\/GRB2 ceRNA network in NSCLC cell malignant proliferation. Comb Chem High Throughput Screen 26(10):1836\u20131847. https:\/\/doi.org\/10.2174\/1386207325666220624093957","journal-title":"Comb Chem High Throughput Screen"},{"issue":"44","key":"1944_CR46","doi-asserted-by":"publisher","first-page":"76015","DOI":"10.18632\/oncotarget.18638","volume":"8","author":"X Wu","year":"2017","unstructured":"Wu X, Dinglin X, Wang X, Luo W, Shen Q, Li Y, Gu L, Zhou Q, Zhu H, Li Y, Tan C, Yang X, Zhang Z (2017) Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101\/EZH2. Oncotarget 8(44):76015\u201376028. https:\/\/doi.org\/10.18632\/oncotarget.18638","journal-title":"Oncotarget"},{"issue":"18","key":"1944_CR47","doi-asserted-by":"publisher","first-page":"9256","DOI":"10.26355\/eurrev_202009_23007","volume":"24","author":"C Xu","year":"2020","unstructured":"Xu C, Tian LH (2020) LncRNA XIST promotes proliferation and epithelial-mesenchymal transition of retinoblastoma cells through sponge action of miR-142-5p. Eur Rev Med Pharmacol Sci 24(18):9256\u20139264. https:\/\/doi.org\/10.26355\/eurrev_202009_23007","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1944_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/0109298665248028231122064831","volume":"31","author":"Z Xu","year":"2024","unstructured":"Xu Z, Yu Y, Ni H, Sun W, Kuang Y (2024) LINC01836 promotes colorectal cancer progression and functions as ceRNA to target SLC17A9 by sponging miR-1226-3p. Protein Pept Lett 31(1):43\u201360. https:\/\/doi.org\/10.2174\/0109298665248028231122064831","journal-title":"Protein Pept Lett"},{"issue":"1","key":"1944_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R (2024) Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci 81(1):79. https:\/\/doi.org\/10.1007\/s00018-023-05099-7","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"1944_CR50","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10142-022-00873-5","volume":"22","author":"Z Yan","year":"2022","unstructured":"Yan Z, Li J, Guo J, He R, Xing J (2022) LncRNA XIST sponges microRNA-448 to promote malignant behaviors of colorectal cancer cells via regulating GRHL2. Funct Integr Genomics 22(5):977\u2013988. https:\/\/doi.org\/10.1007\/s10142-022-00873-5","journal-title":"Funct Integr Genomics"},{"key":"1944_CR52","doi-asserted-by":"publisher","first-page":"101562","DOI":"10.1016\/j.tranon.2022.101562","volume":"26","author":"H Zhang","year":"2022","unstructured":"Zhang H, Shan G, Jin X, Yu X, Bi G, Feng M, Wang H, Lin M, Zhan C, Wang Q, Li M (2022) ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma. Transl Oncol 26:101562. https:\/\/doi.org\/10.1016\/j.tranon.2022.101562","journal-title":"Transl Oncol"},{"issue":"1","key":"1944_CR53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40001-024-01715-9","volume":"29","author":"W Zhang","year":"2024","unstructured":"Zhang W, Xiao P, Liu B, Zhang Y (2024) Circ-10720 as a ceRNA adsorbs microRNA-1238 and modulates ZEB2 to boost NSCLC development by activating EMT. Eur J Med Res 29(1):226. https:\/\/doi.org\/10.1186\/s40001-024-01715-9","journal-title":"Eur J Med Res"},{"issue":"14","key":"1944_CR54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ncrna.2025.06.002","volume":"17","author":"JN Zhang","year":"2025","unstructured":"Zhang JN, Yi ZL, Zhou XR, Liu SS, Liu H (2025) Dual role of lncRNA OTUD6B-AS1 in immune evasion and ferroptosis resistance: a prognostic and therapeutic biomarker in breast cancer. Noncoding RNA Res 17(14):156\u2013165. https:\/\/doi.org\/10.1016\/j.ncrna.2025.06.002","journal-title":"Noncoding RNA Res"},{"issue":"3","key":"1944_CR55","first-page":"1128","volume":"24","author":"D Zhang","year":"2019","unstructured":"Zhang D, Yang N (2019) MiR-335\u20135p inhibits cell proliferation, migration and invasion in colorectal cancer through downregulating LDHB. J BUON 24(3):1128\u20131136","journal-title":"J BUON"},{"issue":"6","key":"1944_CR56","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200525","volume":"40","author":"XM Zhang","year":"2020","unstructured":"Zhang XM, Wang J, Liu ZL, Liu H, Cheng YF, Wang T (2020) LINC00657\/miR-26a-5p\/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2\/p53\/Bcl2\/Bax pathway. Biosci Rep 40(6):BSR20200525. https:\/\/doi.org\/10.1042\/BSR20200525","journal-title":"Biosci Rep"},{"issue":"4","key":"1944_CR57","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/CBM-201740","volume":"30","author":"H Zheng","year":"2021","unstructured":"Zheng H, Zhang M, Ke X, Deng X, Li D, Wang Q, Yan S, Xue Y, Wang Q (2021) LncRNA XIST\/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1. Cancer Biomark 30(4):395\u2013406. https:\/\/doi.org\/10.3233\/CBM-201740","journal-title":"Cancer Biomark"},{"issue":"1","key":"1944_CR58","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1038\/s41598-025-32732-1","volume":"16","author":"R Zhu","year":"2025","unstructured":"Zhu R, Chen J, Zhang X, Chen Q, Jin Y, Zeng M, Luo J, Huang Y, Peng L (2025) Transcriptomics-based analysis of key genes and potential mechanism and therapeutic agents in cadmium-induced esophageal squamous cell carcinoma progression. Sci Rep 16(1):2774. https:\/\/doi.org\/10.1038\/s41598-025-32732-1","journal-title":"Sci Rep"},{"key":"1944_CR59","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today [Internet]. Lyon, France: IARC; 2022 [cited 2025 Aug 2]. Available from: https:\/\/gco.iarc.fr\/today"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01944-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01944-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01944-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:03:15Z","timestamp":1782356595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01944-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01944-7","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the studies involving human participants were in accordance with the ethical standards of the Institutional Ethics committee of All India Institute of Medical Sciences (AIIMS)-Ref. No. IEC-107\/04.02.2022, RP-02\/2022 and Guru Gobind Singh Indraprastha University-Ref. No. GGSIPU\/IEC\/2021-A8, New Delhi, India. A written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Although the present study provides strong in vitro and clinical evidence, the lack of in vivo validation remains a limitation. Future studies using xenograft or PDX models would be valuable to confirm the therapeutic relevance of targeting this axis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Limitation of Study"}}],"article-number":"163"}}